Trial Profile
Real World Study Assessing Hepatitis C Virus Treatment Response to Ledipasvir/Sofosbuvir in Black Patients Co-Infected with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 24 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017.